Yoshikawa, Y., Kawabe, K., Tadokoro, M., Suzuki, Y., Yanagihara, N., Nakayama, A., Sakurai, H. and Kojima, Y. (2002) New Zinc (II) Complexes with Tetradentate Amino Acid Derivatives: Structure Characterization, Solution Chemistry, and in Vitro Insulinomimetic Activity. Bulletin of the Chemical Society of Japan, 75, 2423-2432.
http://dx.doi.org/10.1246/bcsj.75.2423

has been cited by the following article:

• TITLE: α-Glucosidase Inhibition by New Schiff Base Complexes of Zn(II)

  AUTHORS: Rie Miyazaki, Hiroyuki Yasui, Yutaka Yoshikawa

  KEYWORDS: α-Glucosidase Inhibitory Effect, Zn(II) Complexes, Schiff Bases, Diabetes Mellitus

  JOURNAL NAME: Open Journal of Inorganic Chemistry, Vol.6 No.2, April 12, 2016

  ABSTRACT: There are many reports that divalent alkaline earth, first-row transition metals, and Zn(II) ions have α-glucosidase inhibitory effects. Cu(II) and Zn(II) ions, in particular, have strong α-glucosidase inhibitory effects. Several Schiff bases also display α-glucosidase inhibitory effects. In this study, we focused on safe and highly effective complexes including Zn(II) ion. We prepared and characterized the Zn(II) complexes with four different Schiff bases (N-salicylidene-β-alanine (N-sβ), N-N’-bis (salicylidene) ethylenediamine (N-bsE), N, N’-bis (salicylidene)-phenylenediamine (N-bsP), and 1-[(2-dimethylaminoethylimino) methyl]naphtholate (DMN)) and investigated their α-glucosidase inhibitory effects in vitro, using α-glycosidases from Saccharomyces sp. and rat small intestine, and in vivo, using a sucrose tolerance test. The Zn(II) complexes with DMN showed the highest in vitro and in vivo α-glucosidase inhibitory effects in this study.